Embryonic stem cells cure diabetes in mice

Human embryonic stem cells of the (ANSA) – Rome, JUL 2 – in progenitor cells insulin-producing cells to treat diabetes type 1 in mice.

The results published in the journal diabetes was achieved at the Canadian University of British Columbia. Researchers differ from human embryonic stem cells in pancreatic immature that have been transplanted in diabetic mice.

Four months after transplant of animal metabolism was optimal.